138 related articles for article (PubMed ID: 9468244)
21. Azithromycin for the cure of Helicobacter pylori infection.
Di Mario F; Dal Bó N; Grassi SA; Rugge M; Cassaro M; Donisi PM; Vianello F; Kusstatscher S; Salandin S; Grasso GA; Ferrana M; Battaglia G
Am J Gastroenterol; 1996 Feb; 91(2):264-7. PubMed ID: 8607490
[TBL] [Abstract][Full Text] [Related]
22. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
[TBL] [Abstract][Full Text] [Related]
23. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
[TBL] [Abstract][Full Text] [Related]
24. Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection.
Dore MP; Graham DY; Mele R; Marras L; Nieddu S; Manca A; Realdi G
Am J Gastroenterol; 2002 Apr; 97(4):857-60. PubMed ID: 12003419
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole].
Wilhelmsen I; Hundal O; Berstad K; Berstad A
Tidsskr Nor Laegeforen; 1992 Oct; 112(25):3197-9. PubMed ID: 1462293
[TBL] [Abstract][Full Text] [Related]
26. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
27. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Lara LF; Cisneros G; Gurney M; Van Ness M; Jarjoura D; Moauro B; Polen A; Rutecki G; Whittier F
Arch Intern Med; 2003 Sep; 163(17):2079-84. PubMed ID: 14504122
[TBL] [Abstract][Full Text] [Related]
28. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
29. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
Tam YH; Yeung CK; Lee KH
Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
[TBL] [Abstract][Full Text] [Related]
30. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
Vakil N; Cutler A
Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
[TBL] [Abstract][Full Text] [Related]
31. [Alternatives of drug therapy in Helicobacter pylori infections].
Berstad K; Berstad A
Tidsskr Nor Laegeforen; 1994 Mar; 114(8):932-4. PubMed ID: 8191471
[TBL] [Abstract][Full Text] [Related]
32. Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori.
Borody TJ; Brandl S; Andrews P; Ferch N; Jankiewicz E; Hyland L
Am J Gastroenterol; 1994 Jan; 89(1):33-8. PubMed ID: 8273794
[TBL] [Abstract][Full Text] [Related]
33. A 1-h topical therapy for the treatment of Helicobacter pylori infection.
Kimura K; Ido K; Saifuku K; Taniguchi Y; Kihira K; Satoh K; Takimoto T; Yoshida Y
Am J Gastroenterol; 1995 Jan; 90(1):60-3. PubMed ID: 7801950
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Helicobacter pylori infection by topical administration of antimicrobial agents.
Satoh K
Scand J Gastroenterol Suppl; 1996; 214():56; discussion 57-60. PubMed ID: 8722409
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study.
O'Morain C; Borody T; Farley A; De Boer WA; Dallaire C; Schuman R; Piotrowski J; Fallone CA; Tytgat G; Mégraud F; Spénard J;
Aliment Pharmacol Ther; 2003 Feb; 17(3):415-20. PubMed ID: 12562455
[TBL] [Abstract][Full Text] [Related]
36. [Anti-Helicobacter pylori quadruple therapy].
Fukuda Y; Sakagami T
Nihon Rinsho; 2005 Nov; 63 Suppl 11():442-51. PubMed ID: 16363576
[No Abstract] [Full Text] [Related]
37. [Treatment of Helicobacter pylori infection in adults].
Boixeda D
Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():41-7. PubMed ID: 8054370
[No Abstract] [Full Text] [Related]
38. Impact of metronidazole resistance on the eradication of Helicobacter pylori.
Noach LA; Langenberg WL; Bertola MA; Dankert J; Tytgat GN
Scand J Infect Dis; 1994; 26(3):321-7. PubMed ID: 7939433
[TBL] [Abstract][Full Text] [Related]
39. Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains.
Fiorini G; Saracino IM; Zullo A; Gatta L; Pavoni M; Vaira D
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 29094477
[TBL] [Abstract][Full Text] [Related]
40. Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and its resistant strains.
Roghani HS; Massarrat S; Pahlewanzadeh MR; Dashti M
Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):709-12. PubMed ID: 10445787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
